|
시장보고서
상품코드
2058262
상처 치료용 생물학적 제제 시장 : 제품 유형별, 상처 유형별, 최종사용자별, 지역별Wound Care Biologics Market, By Product Type, By Wound Type, By End User, By Geography |
||||||
상처 치료용 생물학적 제제 시장은 2026년에 23억 달러로 추정되며, 2033년까지 37억 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 7.1%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 23억 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 7.10% | 2033년 시장 규모 예측: | 37억 달러 |
상처 치료용 생물학적 제제는 선천적인 회복 기전을 촉진하고, 항산화 작용, 항균 작용 또는 항염증 작용을 나타내는 동물 유래 및 식물 유래 활성 생체분자 등의 활성 생물학적 제제를 사용합니다. 상처 관리용 생체학적 드레싱은 습윤 치유 환경을 제공하고, 열 손실 및 단백질과 전해질의 손실을 촉진하여 치유를 앞당기며, 세균 오염을 방지하기 때문에 수술 후나 중증 외상 사례에서 점점 더 많이 사용되고 있습니다. 생체 피부 대체 제품에는 조직 공학 제품이 포함됩니다. 이것들은 손상된 피부를 일시적 또는 영구적으로 대체하도록 설계되었습니다. 피부 대체 제품은 상처 관리에 널리 사용되며, 욕창, 당뇨병성 신경병증성 궤양, 혈관 기능 부전성 궤양 등 다양한 질환의 치료에 활용되고 있습니다.
시장 역학
당뇨병 유병률의 증가, 외과 수술 건수의 증가, 그리고 외상 사례 증가에 따른 만성 궤양 발생률의 상승이 상처 치료용 생물학적 제제 시장의 성장을 이끄는 주요 촉진요인으로 작용하고 있습니다. 세계보건기구(WHO)의 2014년 조사에 따르면, 교통사고, 익사, 중독, 낙상 또는 화상으로 인한 부상은 전 세계 사망 원인의 9%를 차지하고 있습니다. 또한, 2013년 BMJ 저널 'Injury Prevention'의 연구에 따르면, 의료 처치가 필요한 부상을 입은 사람은 약 9억 7,300만 명, 부상으로 인한 사망자는 480만 명으로 추정되었습니다. 이 잡지는 또한 주요 부상 원인으로 교통사고(29.1%), 자해 행위(17.6%), 넘어짐(11.6%), 타인에 의한 폭력(8.5%)을 꼽고 있습니다. 각 제조사들도 신제품 개발과 제품 포트폴리오 확충을 위해 광범위한 연구 개발에 주력하고 있습니다. 예를 들어, 2016년에는 인테그라 라이프사이언시스 홀딩스(Integra LifeSciences Holdings)가 당뇨병성 족부궤양 치료제로서 '인테그라 더말 리제네레이션 템플릿(IDRT)'의 FDA 승인을 획득했습니다. 본 제품은 '인테그라 옴니그래프트 더말 리제너레이션 매트릭스'라는 이름으로 판매되고 있습니다. 또한, 바이오의약품에 대한 대중의 인식이 높아진 점도 시장 성장에 기여하고 있습니다. 이는 만성 상처 형성에 따른 발병률을 최소화하기 위해 상처 예방을 위한 고도의 의료 서비스를 선택하는 사람들이 늘어나고 있기 때문입니다. 그러나 바이오의약품의 높은 비용과 혁신적인 조직공학 제품의 출시를 위한 엄격한 규제 승인이 상처 치료용 생물학적 제제 시장의 성장을 저해하고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 지표를 바탕으로 전 세계 상처 치료용 생물학적 제제 시장의 주요 기업 개요을 작성하였습니다 : 기업 개요, 재무 실적, 제품 포트폴리오, 시장 입지, 유통 전략, 주요 발전 및 전략, 그리고 향후 계획.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 기술 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계의 상처 치료용 생물학적 제제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 상처 치료용 생물학적 제제 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 상처 치료용 생물학적 제제 시장 : 제품 유형별, 2021-2033년
제5장 세계의 상처 치료용 생물학적 제제 시장 : 상처 종류별, 2021-2033년
제6장 세계의 상처 치료용 생물학적 제제 시장 : 최종사용자별, 2021-2033년
제7장 세계의 상처 치료용 생물학적 제제 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSMWound Care Biologics Market is estimated to be valued at USD 2.3 Bn in 2026 and is expected to reach USD 3.7 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2.3 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.10% | 2033 Value Projection: | USD 3.7 Bn |
Wound care biologic products facilitates in innate repair mechanisms, and involves the use of active biological agents such as animal and plant-derived active biomolecules, which exhibit antioxidant, antimicrobial, or anti-inflammatory properties. Wound care biologic dressings are increasingly being used in post surgeries and severe trauma cases as they provide moist healing environment aiding heat loss, protein and electrolyte loss for faster healing, and prevent bacterial contamination. Biologic skin substitute products include tissue-engineered products, which are designed to either temporarily or permanently replace the altered skin. Skin substitutes are commonly used products for wound management and have application for treating various ailments such as pressure ulcers, diabetic neuropathic ulcers, and vascular insufficiency ulcers.
Market Dynamics
Increasing incidences of chronic ulcers, owing to rising prevalence of diabetes, increasing surgical procedures, and rise in trauma cases are major driving factors for growth of wound care biologics market. According to the survey by World Health Organization, 2014, injuries resulting from traffic collisions, drowning, poisoning, falls or burns account for 9% of the global mortality. Also, according to a study by BMJ Journal Injury Prevention, 2013, an estimated 973 million people sustained injuries that warranted some type of healthcare and 4.8 million people died from injuries. The Journal also stated that major injury causes included road injury (29.1%), self-harm (17.6%), falls (11.6%), and interpersonal violence (8.5%). Manufacturers are also focused on extensive research and development to develop new products and expand their product portfolio. For instance, in 2016, Integra LifeSciences Holdings Corporation received FDA approval for Integra Dermal Regeneration Template (IDRT) for the treatment of diabetic foot ulcers that is marketed under the name of Integra Omnigraft Dermal Regeneration Matrix. Moreover, public awareness for biologics has positively contributed to the market growth, as people are opting for enhanced medical care for preventing wounds to minimize the morbidity associated with the formation of chronic wounds. However, higher cost of the biologics and stringent regulatory approvals for launch of innovative tissue engineered products are hindering growth of the wound care biologics market.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
- It profiles leading players in the global wound care biologics market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, and strategies, and future plans
- Key companies covered as a part of this study include Smith & Nephew Plc., Organogenesis, Inc., Integra Lifesciences Holdings Corporation, Skye Biologics, Alphatec Holdings, Inc., Solsys Medical LLC, Amino Technology LLC, and Osiris Therapeutics, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global wound care biologics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the wound care biologics market
Market Segmentation
- By Product Type (Revenue, USD Bn, 2021-2033)
- Skin Substitute
- Biological
- Allografts
- Xenografts
- Others
- Synthetic
- Topical Agents
- By Wound Type (Revenue, USD Bn, 2021-2033)
- Chronic Wounds
- Diabetic Foot Ulcers (DFU)
- Venous Leg Ulcers
- Others
- Acute Wounds
- Burns
- Surgical & Traumatic Wounds
- Others
- By End User (Revenue, USD Bn, 2021-2033)
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Home Care Settings
- Others
- By Region (Revenue, USD Bn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Competitive Landscape
- Smith & Nephew Plc.
- Organogenesis, Inc.
- Integra Lifesciences Holdings Corporation
- Skye Biologics
- Alphatec Holdings, Inc.
- Solsys Medical LLC
- Amino Technology LLC
- Osiris Therapeutics, Inc.
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Wound Type
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Industry Trends
- Technological Advancements
- Regulatory Scenario
- Reimbursement Scenario
- Key Highlights
- PEST Analysis
- Epidemiology
- Impact Analysis
4. Global Wound Care Biologics Market, By Product Type, 2021-2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Skin Substitute
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Biological
- Allografts
- Xenografts
- Others
- Synthetic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Topical Agents
5. Global Wound Care Biologics Market, By Wound Type, 2021-2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Chronic Wounds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Segment Trends
- Diabetic Foot Ulcers (DFU)
- Venous Leg Ulcers
- Others
- Acute Wounds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Segment Trends
- Burns
- Surgical & Traumatic Wounds
- Others
6. Global Wound Care Biologics Market, By End User, 2021-2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Segment Trends
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
7. Global Wound Care Biologics Market, By Region, 2021-2033, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2033
- North America
- Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
- Market Size and Forecast, By Wound Type, 2021-2033, (US$ Billion)
- Market Size and Forecast, By End User, 2021-2033, (US$ Billion)
- Market Size and Forecast, By Country, 2021-2033, (US$ Billion)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
- Market Size and Forecast, By Wound Type, 2021-2033, (US$ Billion)
- Market Size and Forecast, By End User, 2021-2033, (US$ Billion)
- Market Size and Forecast, By Country, 2021-2033, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
- Market Size and Forecast, By Wound Type, 2021-2033, (US$ Billion)
- Market Size and Forecast, By End User, 2021-2033, (US$ Billion)
- Market Size and Forecast, By Country, 2021-2033, (US$ Billion)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
- Market Size and Forecast, By Wound Type, 2021-2033, (US$ Billion)
- Market Size and Forecast, By End User, 2021-2033, (US$ Billion)
- Market Size and Forecast, By Country, 2021-2033, (US$ Billion)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
- Market Size and Forecast, By Wound Type, 2021-2033, (US$ Billion)
- Market Size and Forecast, By End User, 2021-2033, (US$ Billion)
- Market Size and Forecast, By Country, 2021-2033, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
- Market Size and Forecast, By Wound Type, 2021-2033, (US$ Billion)
- Market Size and Forecast, By End User, 2021-2033, (US$ Billion)
- Market Size and Forecast, By Country, 2021-2033, (US$ Billion)
- South Africa
- Central Africa
- North Africa
8. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis (3x3 Matrix)
- Company Profiles
- Smith & Nephew Plc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Market Strategies
- Organogenesis, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Market Strategies
- Integra Lifesciences Holdings Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Market Strategies
- Skye Biologics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Market Strategies
- Alphatec Holdings, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Market Strategies
- Solsys Medical LLC
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Market Strategies
- Amino Technology LLC
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Market Strategies
- Osiris Therapeutics, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Market Strategies
- Analyst Views
- Smith & Nephew Plc
9. Section
- References
- Research Methodology
- About us and Sales Contact
